世界の遅発性ジスキネジア(TD)治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Tardive Dyskinesia (TD) Treatment Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6032 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、遅発性ジスキネジア(TD)治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バルベナジン、デュテトラベナジン）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・遅発性ジスキネジア(TD)治療薬の市場動向 ・企業の競争状況、市場シェア ・遅発性ジスキネジア(TD)治療薬の種類別市場規模と予測2016-2027（バルベナジン、デュテトラベナジン） ・遅発性ジスキネジア(TD)治療薬の用途別市場規模と予測2016-2027（病院、診療所、その他） ・遅発性ジスキネジア(TD)治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・遅発性ジスキネジア(TD)治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・遅発性ジスキネジア(TD)治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・遅発性ジスキネジア(TD)治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・遅発性ジスキネジア(TD)治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Neurocrine Biosciences, Inc.、Teva Pharmaceutical Industries、Pfizer Inc.、Biogen、Novartis AG、AstraZeneca、GlaxoSmithKline plc.、Bayer AG、Sanofi） ・結論

Tardive dyskinesia is a type of neurological disorder, which characterized the blink your eyes fast, chew, smack or pucker of lips, puff out your cheeks, tongue and others. The patients treating with neuroleptic drugs or anti-psychotic medications can also be the cause of tardive dyskinesia. Tardive dyskinesia is difficult to treat as treatment process is also not confirmed and the drug is also not approved in various conditions. The treatment of tardive dyskinesia is directly affect the neurological system of the respective patients. This disorder may commonly occurs in smoker than non-smoker, and also in the patient of depression, anxiety disorder and others.

Market Analysis and Insights: Global Tardive Dyskinesia (TD) Treatment Drugs Market
The global Tardive Dyskinesia (TD) Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tardive Dyskinesia (TD) Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tardive Dyskinesia (TD) Treatment Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tardive Dyskinesia (TD) Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tardive Dyskinesia (TD) Treatment Drugs market.

Global Tardive Dyskinesia (TD) Treatment Drugs Scope and Market Size
Tardive Dyskinesia (TD) Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tardive Dyskinesia (TD) Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Valbenazine
Deutetrabenazine

Segment by Application
Hospitals
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Neurocrine Biosciences, Inc.
Teva Pharmaceutical Industries
Pfizer Inc.
Biogen
Novartis AG
AstraZeneca
GlaxoSmithKline plc.
Bayer AG
Sanofi

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Valbenazine
1.2.3 Deutetrabenazine
1.3 Market by Application
1.3.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Perspective (2016-2027)
2.2 Tardive Dyskinesia (TD) Treatment Drugs Growth Trends by Regions
2.2.1 Tardive Dyskinesia (TD) Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tardive Dyskinesia (TD) Treatment Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Tardive Dyskinesia (TD) Treatment Drugs Industry Dynamic
2.3.1 Tardive Dyskinesia (TD) Treatment Drugs Market Trends
2.3.2 Tardive Dyskinesia (TD) Treatment Drugs Market Drivers
2.3.3 Tardive Dyskinesia (TD) Treatment Drugs Market Challenges
2.3.4 Tardive Dyskinesia (TD) Treatment Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Tardive Dyskinesia (TD) Treatment Drugs Players by Revenue
3.1.1 Global Top Tardive Dyskinesia (TD) Treatment Drugs Players by Revenue (2016-2021)
3.1.2 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tardive Dyskinesia (TD) Treatment Drugs Revenue
3.4 Global Tardive Dyskinesia (TD) Treatment Drugs Market Concentration Ratio
3.4.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tardive Dyskinesia (TD) Treatment Drugs Revenue in 2020
3.5 Tardive Dyskinesia (TD) Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Tardive Dyskinesia (TD) Treatment Drugs Product Solution and Service
3.7 Date of Enter into Tardive Dyskinesia (TD) Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Tardive Dyskinesia (TD) Treatment Drugs Breakdown Data by Type
4.1 Global Tardive Dyskinesia (TD) Treatment Drugs Historic Market Size by Type (2016-2021)
4.2 Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Type (2022-2027)

5 Tardive Dyskinesia (TD) Treatment Drugs Breakdown Data by Application
5.1 Global Tardive Dyskinesia (TD) Treatment Drugs Historic Market Size by Application (2016-2021)
5.2 Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size (2016-2027)
6.2 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
6.2.1 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2016-2021)
6.2.2 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2022-2027)
6.2.3 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2016-2027)
6.3 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
6.3.1 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2016-2021)
6.3.2 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2022-2027)
6.3.3 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2016-2027)
6.4 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country
6.4.1 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2016-2021)
6.4.2 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size (2016-2027)
7.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
7.2.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2016-2021)
7.2.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2022-2027)
7.2.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2016-2027)
7.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
7.3.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2016-2021)
7.3.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2022-2027)
7.3.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2016-2027)
7.4 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country
7.4.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2016-2021)
7.4.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size (2016-2027)
8.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
8.2.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
8.3.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region
8.4.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size (2016-2027)
9.2 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
9.2.1 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2016-2027)
9.3 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
9.3.1 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2016-2027)
9.4 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country
9.4.1 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size (2016-2027)
10.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
10.2.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
10.3.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country
10.4.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Neurocrine Biosciences, Inc.
11.1.1 Neurocrine Biosciences, Inc. Company Details
11.1.2 Neurocrine Biosciences, Inc. Business Overview
11.1.3 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Introduction
11.1.4 Neurocrine Biosciences, Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021)
11.1.5 Neurocrine Biosciences, Inc. Recent Development
11.2 Teva Pharmaceutical Industries
11.2.1 Teva Pharmaceutical Industries Company Details
11.2.2 Teva Pharmaceutical Industries Business Overview
11.2.3 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Introduction
11.2.4 Teva Pharmaceutical Industries Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021)
11.2.5 Teva Pharmaceutical Industries Recent Development
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Details
11.3.2 Pfizer Inc. Business Overview
11.3.3 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Introduction
11.3.4 Pfizer Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021)
11.3.5 Pfizer Inc. Recent Development
11.4 Biogen
11.4.1 Biogen Company Details
11.4.2 Biogen Business Overview
11.4.3 Biogen Tardive Dyskinesia (TD) Treatment Drugs Introduction
11.4.4 Biogen Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021)
11.4.5 Biogen Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Introduction
11.5.4 Novartis AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021)
11.5.5 Novartis AG Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Introduction
11.6.4 AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 GlaxoSmithKline plc.
11.7.1 GlaxoSmithKline plc. Company Details
11.7.2 GlaxoSmithKline plc. Business Overview
11.7.3 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Introduction
11.7.4 GlaxoSmithKline plc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021)
11.7.5 GlaxoSmithKline plc. Recent Development
11.8 Bayer AG
11.8.1 Bayer AG Company Details
11.8.2 Bayer AG Business Overview
11.8.3 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Introduction
11.8.4 Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021)
11.8.5 Bayer AG Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Introduction
11.9.4 Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021)
11.9.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Valbenazine
Table 3. Key Players of Deutetrabenazine
Table 4. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Regions (2016-2021)
Table 8. Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Regions (2022-2027)
Table 10. Tardive Dyskinesia (TD) Treatment Drugs Market Trends
Table 11. Tardive Dyskinesia (TD) Treatment Drugs Market Drivers
Table 12. Tardive Dyskinesia (TD) Treatment Drugs Market Challenges
Table 13. Tardive Dyskinesia (TD) Treatment Drugs Market Restraints
Table 14. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Players (2016-2021)
Table 16. Global Top Tardive Dyskinesia (TD) Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tardive Dyskinesia (TD) Treatment Drugs as of 2020)
Table 17. Ranking of Global Top Tardive Dyskinesia (TD) Treatment Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Tardive Dyskinesia (TD) Treatment Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Tardive Dyskinesia (TD) Treatment Drugs Product Solution and Service
Table 21. Date of Enter into Tardive Dyskinesia (TD) Treatment Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Neurocrine Biosciences, Inc. Company Details
Table 62. Neurocrine Biosciences, Inc. Business Overview
Table 63. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Product
Table 64. Neurocrine Biosciences, Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021) & (US$ Million)
Table 65. Neurocrine Biosciences, Inc. Recent Development
Table 66. Teva Pharmaceutical Industries Company Details
Table 67. Teva Pharmaceutical Industries Business Overview
Table 68. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product
Table 69. Teva Pharmaceutical Industries Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021) & (US$ Million)
Table 70. Teva Pharmaceutical Industries Recent Development
Table 71. Pfizer Inc. Company Details
Table 72. Pfizer Inc. Business Overview
Table 73. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Product
Table 74. Pfizer Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021) & (US$ Million)
Table 75. Pfizer Inc. Recent Development
Table 76. Biogen Company Details
Table 77. Biogen Business Overview
Table 78. Biogen Tardive Dyskinesia (TD) Treatment Drugs Product
Table 79. Biogen Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021) & (US$ Million)
Table 80. Biogen Recent Development
Table 81. Novartis AG Company Details
Table 82. Novartis AG Business Overview
Table 83. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product
Table 84. Novartis AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021) & (US$ Million)
Table 85. Novartis AG Recent Development
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product
Table 89. AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021) & (US$ Million)
Table 90. AstraZeneca Recent Development
Table 91. GlaxoSmithKline plc. Company Details
Table 92. GlaxoSmithKline plc. Business Overview
Table 93. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Product
Table 94. GlaxoSmithKline plc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021) & (US$ Million)
Table 95. GlaxoSmithKline plc. Recent Development
Table 96. Bayer AG Company Details
Table 97. Bayer AG Business Overview
Table 98. Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021) & (US$ Million)
Table 99. Bayer AG Recent Development
Table 100. Sanofi Company Details
Table 101. Sanofi Business Overview
Table 102. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product
Table 103. Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021) & (US$ Million)
Table 104. Sanofi Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type: 2020 VS 2027
Figure 2. Valbenazine Features
Figure 3. Deutetrabenazine Features
Figure 4. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Tardive Dyskinesia (TD) Treatment Drugs Report Years Considered
Figure 9. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Regions: 2020 VS 2027
Figure 12. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Regions (2022-2027)
Figure 13. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Players in 2020
Figure 14. Global Top Tardive Dyskinesia (TD) Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tardive Dyskinesia (TD) Treatment Drugs as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Tardive Dyskinesia (TD) Treatment Drugs Revenue in 2020
Figure 16. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Type (2022-2027)
Figure 18. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2016-2027)
Figure 20. North America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2016-2027)
Figure 21. North America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Country (2016-2027)
Figure 22. United States Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2016-2027)
Figure 26. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2016-2027)
Figure 27. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Share by Country (2016-2027)
Figure 28. Germany Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Share by Region (2016-2027)
Figure 38. China Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2016-2027)
Figure 46. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2016-2027)
Figure 47. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Country (2016-2027)
Figure 48. Mexico Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Share by Country (2016-2027)
Figure 54. Turkey Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Neurocrine Biosciences, Inc. Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021)
Figure 58. Teva Pharmaceutical Industries Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021)
Figure 59. Pfizer Inc. Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021)
Figure 60. Biogen Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021)
Figure 61. Novartis AG Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021)
Figure 63. GlaxoSmithKline plc. Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021)
Figure 64. Bayer AG Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---